Host: Matt Birnholz, MD <br>

Guest: Hans Petter Eikesdal, MD <br>


  <p>At the 2019 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain, Dr. Matt Birnholz got a chance to talk with Dr. Hans Petter Eikesdal about the head-turning study on PARP inhibitors he presented at the conference.</p>

Host: Matt Birnholz, MD Guest: Hans Petter Eikesdal, MD At the 2019 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain, Dr. Matt Birnholz got a chance to talk with Dr. Hans Petter Eikesdal about the head-turning study on PARP inhibitors he presented at the conference.

Are PARP Inhibitors the Future of Treating Triple-Negative Breast Cancer?

Advances in Women’s Health addresses advances, breakthroughs, and treatments for conditions related to women’s health, as well as preventive measures physicians can advise their patients to pursue. Topics will include breast health as it relates to cancer, ethnicity, fertility, and pregnancy; osteoporosis; female athletes’ health and emotional issues; mental health; pregnancy and all facets related to it; aging; nutrition and health; eating disorders; alternative medicine; and sex education.

Share Are PARP Inhibitors the Future of Treating Triple-Negative Breast Cancer?

Sign up to save your podcasts

Are PARP Inhibitors the Future of Treating Triple-Negative Breast Cancer?

Are PARP Inhibitors the Future of Treating Triple-Negative Breast Cancer?

More shows like Advances in Women's Health

Medical Industry Feature

SexMed

Partners in Practice

Second Opinion LIVE!

Medical Breakthroughs from Penn Medicine

GI Insights

Conference Coverage

HOT For Your Health

Up First from NPR

You Are Not Broken

Dr. Streicher’s Inside Information: Menopause, Midlife, and More